Kvíz spojený s průvodcem · Střední úroveň
WHO Guidance on AI in Health Quiz
Tests WHO ethical principles, autonomy, accountability, equity, lifecycle governance, and distinction from product certification.
Otázka 1 z 8
Co poskytuje doporučení WHO týkající se umělé inteligence ve zdraví?
Náhled každé otázky8 otázky
Odpovědi a vysvětlení se zobrazují, jak budete v kvízu.
- Co poskytuje doporučení WHO týkající se umělé inteligence ve zdraví?
- A risk-based checklist that substitutes for national health law
- Ethical and governance principles for responsible AI use
- A binding regulation adopted by every WHO member state
- A product-certification scheme for vendors
- What does protecting human autonomy mean in WHO’s framework?
- Autonomy applies to data consent but not decisions about care
- A clinician’s approval alone satisfies autonomy even without patient involvement
- People remain in control of health systems and medical decisions
- Patients must override any clinical recommendation in every circumstance
- Why establish a redress mechanism?
- People need a way to question and seek a response to harmful algorithmic decisions
- A complaint form with no review or response pathway
- An updated score without explanation or remedy
- An operator may close complaints without examining them
- How should inclusion and equity affect AI governance?
- Assess who benefits, who may be excluded, and access across groups
- Use the same aggregate score for every group without examining access
- Prioritize availability to well-resourced hospitals because they produce more data
- Treat equal model outputs as proof that access is equitable
- Jsou pokyny WHO certifikací produktu?
- Yes; WHO guidance replaces local approval whenever a tool is used clinically
- No; it is a governance framework and does not replace local regulation
- Yes; publication by WHO certifies a vendor’s product
- No; WHO guidance applies only to medical-device manufacturers
- When should an organization revisit governance controls?
- Only before initial deployment because later review invalidates evaluation
- When data or a model changes, but not when clinical workflow changes
- Only after a regulator orders review
- When models, data, or workflows change
- Které zveřejnění nejpříměji vysvětluje zamýšlené použití, důkazy a omezení nástroje AI pro zdraví?
- Accessible documentation of intended use, evidence, and limitations
- An aggregate accuracy score without use conditions or limitations
- Source code without evidence or intended-use information
- An internal report unavailable to health workers and affected users
- Kdo nese odpovědnost za etickou AI ve zdraví?
- Health ministries and vendors, excluding clinicians and communities
- Developers and regulators, excluding care providers and patients
- Developers, providers, governments, and affected people
- Patients and vendors alone, without health systems or public agencies